In addition, cancer/AML progenitor cells exhibited imbalanced heme biosynthesis, inferred and exemplified by elevated gene expression for enzymes that catalyze the intermediate steps of heme biosynthesis, for example, HMBS and UROD (Fig 3D and E). The gene discussed is UROD; the disease is cancer.